COMBINAISON D'UNE THERAPIE PHOTODYNAMIQUE ET D'AGENTS ANTI-VEGF DANS LE TRAITEMENT D'UNE NEOVASCULARISATION CHROROIDIENNE INDESIRABLE

• 收藏
• 分享

专利权人:

QLT INC.

发明人:

STRONG, ANDREW,HAO, YONG

申请号：

CA2747219

公开号：

CA2747219C

申请日:

2009.12.16

申请国别(地区):

CA

年份:

2017

代理人:

摘要：

The use of a combination of photodynamic therapy and an anti-VEGF agent in thetreatment of conditions characterizedby unwanted choroidal neovasculature is described. These conditions includewet age-related macular degeneration Preferredanti-VEGF agents are antibodies such as bevacizumab or ranibizumabPhotosensitizers may be selected from green porphyrinssuch as BPD-MA (verteporfin) and the photodynamic activation of thephotosensitizer may be accomplished using a reducedfluence rate. The use may further comprises an anti-inflammatory agent such adexamethasone.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/